Jupiter Life Line Hospitals IPO
Jupiter Life Line Hospitals IPO — date, price band, lot size & details 2023
Jupiter Life Line Hospitals listed on 18 Sep 2023 at ₹973, 32.4% above the ₹735 issue price.
Jupiter Life Line Hospitals is a multi-specialty tertiary and quaternary healthcare provider with hospitals in Thane, Pune and Indore. It had 1,194 beds on 31 March 2023.
Stock price
Jupiter Life Line Hospitals is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 11 November.
- Open 06 Sep 2023
- Close 08 Sep 2023
- Allotment 13 Sep 2023
- Refund/credit 14 Sep 2023
- Listing 18 Sep 2023
Issue summary
The terms of the offer, as filed.
| IPO Dates | 6 to 8 Sep, 2023 |
|---|---|
| Price Band | ₹695 – ₹735 |
| Face Value | ₹10 |
| Lot Size | 20 Shares |
| Issue Size | ₹869.08 Cr |
| Sale Type | Fresh capital cum OFS |
| Listing On | BSE, NSE |
| Registrar | KFin Technologies Limited |
| Min Investment | ₹ 14,700 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 20 shares at the ₹735 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 20 | ₹14,700 |
| Retail (max) | 13 | 260 | ₹1,91,100 |
| S-HNI (min) | 14 | 280 | ₹2,05,800 |
| S-HNI (max) | 68 | 1,360 | ₹9,99,600 |
| B-HNI (min) | 69 | 1,380 | ₹10,14,300 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 5
- 01Total income rose from Rs 490.27 crore in FY2021 to Rs 902.96 crore in FY2023.
- 02Profit after tax rose from a loss of Rs 2.30 crore in FY2021 to Rs 72.91 crore in FY2023.
- 03Rs 510.16 crore of the fresh issue was planned for repaying debt.
- 04It had 1,194 beds and 1,306 doctors across 3 hospitals.
- 05The source puts return on net worth at 20.03%.
Risks · 5
- 01The pre-issue P/E was 52.68 at the upper band of Rs 735, as per the source.
- 02Total borrowing was Rs 468.63 crore on 31 March 2023, above net worth of Rs 363.91 crore.
- 03The new Dombivli hospital of over 500 beds needs heavy spending and time to fill beds.
- 04Promoters and the promoter group held only 49.79% before the issue and 40.91% after it.
- 05Rs 327.08 crore of the issue was offer for sale, so that part did not reach the company.
Three years of numbers
All figures in ₹ crore, as reported in the Jupiter Life Line Hospitals offer document.
| Metric | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Assets | 985.53 | 908.70 | 788.91 |
| Total Income | 902.96 | 737.14 | 490.27 |
| Profit After Tax | 72.91 | 51.13 | -2.30 |
| NET Worth | 363.91 | 288.43 | 246.44 |
| Total Borrowing | 468.63 | 495.25 | 425.52 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Jupiter Life Line Hospitals RHP. EPS and P/E are post-issue — the table below carries the pre-issue comparison.
Jupiter Life Line Hospitals IPO Valuation
How the issue prices the company before and after the fresh shares are created.
| Valuation Metric | Pre-Issue | Post-Issue |
|---|---|---|
| P/E Ratio (x) | 52.68 | 66.10 |
Pre-issue figures use the shareholding reported in the RHP; post-issue figures use the shareholding once the fresh issue has created new shares. The two differ because of that dilution and because post-issue earnings per share are often annualised, so the change can run in either direction. Market capitalisation is calculated at the ₹735 offer price. Compare the post-issue P/E against listed peers before deciding — a premium there is growth you are paying for in advance.
Where the money goes
₹511.32 Cr of the issue is earmarked to named objects.
About the company
It has operated for over 15 years and runs three hospitals at Thane, Pune and Indore under the Jupiter brand, with total capacity of 1,194 beds on 31 March 2023. It had 1,306 doctors, including specialists, physicians and surgeons.
It is building a multi-specialty hospital in Dombivli, Maharashtra, designed for over 500 beds, where construction began in April 2023.
The IPO was Rs 869.08 crore, with Rs 542.00 crore of fresh issue and Rs 327.08 crore of offer for sale by investors, promoter group members and other shareholders. Rs 510.16 crore was planned for repaying borrowings of the company and its material subsidiary.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Jupiter Life Line Hospitals IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
JM Financial Ltd.
125 issues handledBest listing: Tata Technologies (+140.0%). Weakest: ACME Solar Holdings (-13.1%).
Nuvama Wealth Management Ltd.
42 issues handledBest listing: Gandhar Oil Refinery (India) (+76.3%). Weakest: ACME Solar Holdings (-13.1%).
ICICI Securities
133 issues handledBest listing: Latent View Analytics (+160.0%). Weakest: Shriram Properties (-23.7%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Jupiter Life Line Hospitals?
The current Grey Market Premium is ₹240, or 33% over the issue price.
What is the Jupiter Life Line Hospitals IPO price band?
₹695 to ₹735, on a face value of ₹10.
When is the allotment?
The basis of allotment is 13 September 2023, with listing on 18 September 2023.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — KFin Technologies Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
